Alkomiet Hasan
born 1982
Member since 2016
subject: Psychiatry, Psychotherapy, Clinical Neuroscience
Contact
Klinikum der Universität München
Klinik und Poliklinik für Psychiatrie and Psychotherapie
Nußbaumstr. 7
80336 München
Tel.: (089) 44 00-555 36
Fax: (089) 44 00-555 30
alkomiet.hasan@med.uni-muenchen.de
Research Areas
Schizophrenia and other psychotic disorders
Human Neurophysiology and Clinical Neurophysiology
Evidence-based medicine
Clinical Research and clinical trials
Curriculum Vitae
-
since 2015
Vice Chairman, Department of Psychiatry and Psychotherapy, LMU Munich
-
2014
DGBP Research Prize for Systematic Neurosciences
-
2014
Consultant for Psychiatry, LMU Munich
-
2014
Board-certification for Psychiatry and Psychotherapy
-
2013
DGPPN Research Prize for Biological Psychiatry
-
2013
Aretaeus Schizophrenia Research Prize
-
2013
Habilitation (Venia docendi, Venia legend), Faculty of Medicine, LMU Munich
-
2012
Young Investigator Award International Congress on Schizophrenia Research
-
2010
DFG-Research Grant (University College London)
-
2008
Doctoral Thesis (Dr. med.), Faculty of Medicine, Georg-August University Göttingen
-
2008
Lincence to practice medicine
-
2002 - 2008
Studies of Medicine, Georg-August University Göttingen
Activities
Publications
-
Cognitive Effects of High-Frequency rTMS in Schizophrenia Patients With Predominant Negative Symptoms: Results From a Multicenter Randomized Sham-Controlled Trial
Hasan A, Guse B, Cordes J, Wölwer W, et al. (2016): Cognitive Effects of High-Frequency rTMS in Schizophrenia Patients With Predominant Negative Symptoms: Results From a Multicenter Randomized Sham-Controlled Trial, Schizophr Bull. 42(3):608-18.
-
Left prefrontal high-frequency rTMS for the Treatment of Schizophrenia with Predominant Negative Symptoms - A Sham-controlled, Randomized Multicentre Trial
Wobrock T, Guse B, Cordes J, Wölwer W, Winterer G, Gaebel W, Langguth B, Landgrebe M, Peter Eichhammer, Frank E, Hajak G, Ohmann C, Verde PE, Rietschel M, Ahmed R, Honer WG, Malchow B, Schneider-Axmann T, Falkai P, Hasan A (2015): Left prefrontal high-frequency rTMS for the Treatment of Schizophrenia with Predominant Negative Symptoms - A Sham-controlled, Randomized Multicentre Trial, Biological Psychiatry, 1;77(11):979-88
-
Guidelines for Biological Treatment of Schizophrenia
Hasan A, Falkai P, Wobrock T, Lieberman J, Glenthoj B, Gattaz WF, Thibaut F, Möller HJ; the WFSBP Task Force on Treatment Guidelines for Schizophrenia (2012): World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, Part 1: Update 2012 on the acute treatment of schizophrenia and the management of treatment resistance. World J Biol Psychiatry. 13(5):318-378
-
Nationale und internationale Leitlinien zur Schizophrenie
Hasan A, Wobrock T, Gaebel W, Janssen B, Zielasek J, Falkai P (2013): Nationale und internationale Leitlinien zur Schizophrenie – Update 2013 zum Stand der Empfehlungen zur antipsychotischen Medikation, Der Nervenarzt, 84(11):1359-60
